On May 8, 2025, Axsome Therapeutics announced they secured a Loan Agreement for up to $570 million and entered a securities purchase agreement to sell 140,000 shares at $107.14 each, raising approximately $15 million. The funds will help repay an existing loan with Hercules Capital.